¼¼°èÀÇ °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ - À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges), By Application (Pain Management, Smoking Cessation, Angina Pectoris), By End-use, By Region, And Segment Forecast, 2024 - 2030
»óǰÄÚµå : 1529610
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,374,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,782,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,597,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 65¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 6.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛÀº Áö³­ 10³â µ¿¾È Å« ±â¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ùȸ Åë°ú ´ë»ç ¹èÁ¦, pH °¨¼ö¼ºÀÌ ³ôÀº ¾àÁ¦ÀÇ ½Å¼ÓÇÑ Èí¼ö, À§»ê°úÀÇ »óÈ£ÀÛ¿ëÀÌ ¾ø°í, ±¸°­³» Åõ¿©º¸´Ù ½Å¼ÓÇÑ ÀÛ¿ë ¹ßÇö, ÃÖ¼ÒÇÑÀÇ ºÎÀÛ¿ë, ¾àÁ¦ ºÐÇØ Àú°¨ µîÀÌ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù. °æ±¸ ¾à¹°Àü´ÞÀº ³ëÀΰú »ïŰ´Â ¾î·Á¿î ȯÀÚ¿¡°Ô ³Î¸® ¹Þ¾Æ µé¿©Áý´Ï´Ù.

Generex, NovaDel, Biodiversity Sciences International, Transcept Pharmaceuticals µîÀÇ ´ë±â¾÷Àº Àν¶¸°, ÇìÆÄ¸°, ¸ð¸£ÇÉ, Àå½Ã°£ Áö¼ÓÀûÀÎ ÁøÅëÁ¦, ÀϺΠÇ×½ÉÀå¾à µîÀÇ Áß¿äÇÑ ¾àÀ» ±Þ¼Ó ¹Ì½ºÆ®, Á¡Âø µð½ºÅ©, ·ÎÁ¨Áö µî ¿¡ ²÷ÀÓ¾øÀÌ °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿¬±¸°¡ »ó¾÷È­µÇ¸é ¾àÈ¿ ¹ßÇöÀÌ ´õ »¡¶óÁö°í ¾à¹°ÀÇ ¿­È­°¡ ¾ø¾îÁö±â ¶§¹®¿¡ °á±¹ ÀλýÀÇ Å« ±¸¼¼ÁÖ°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀå °ü°èÀÚµé »çÀÌ¿¡¼­ ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÇØÁ³À½¿¡µµ ºÒ±¸Çϰí COVID-19 ÆÒµ¥¹ÍÀÇ ¹ß»ýÀ¸·Î ¸ÅÃâ ¹× ¼öÀÍÀÇ ±Þ°ÝÇÑ °¨¼Ò°¡ °üÂûµÇ¾ú½À´Ï´Ù. COVID ÀÌ¿ÜÀÇ ÀǾàǰ ½ÃÀåµµ Å« Ÿ°ÝÀ» ¹Þ¾Æ °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ Ä§Ã¼·Î À̾îÁ³½À´Ï´Ù. ±×·¯³ª 2022³â±îÁö´Â ȸº¹µÈ °ÍÀ¸·Î Æò°¡µË´Ï´Ù.

°æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ® :

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ±¸°­³» ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ ¹× ¹üÀ§

Á¦4Àå ±¸°­³» ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : À¯Çüº° ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦5Àå ±¸°­³» ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦6Àå ±¸°­³» ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå ±¸°­³» ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº° ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Buccal Drug Delivery Systems Market Growth & Trends:

The global buccal drug delivery systems market size is expected to reach USD 6.56 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 6.2% from 2024 to 2030. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.

Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022.

Buccal Drug Delivery Systems Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Buccal Drug Delivery Systems Market Variables, Trends, & Scope

Chapter 4. Buccal Drug Delivery Systems Market: Type Estimates & Trend Analysis

Chapter 5. Buccal Drug Delivery Systems Market: Application Estimates & Trend Analysis

Chapter 6. Buccal Drug Delivery Systems Market: End Use Estimates & Trend Analysis

Chapter 7. Buccal Drug Delivery Systems Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â